Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00912041 · ClinicalTrials.gov registry record · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
A NA study of Spinal Cord Injuries and Amyotrophic Lateral Sclerosis, sponsored by Leigh R. Hochberg, MD, PhD..
- Recruiting
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 5
- Study locations
NCT00912041: Recruiting NA study of Spinal Cord Injuries and Amyotrophic Lateral Sclerosis, sponsored by Leigh R. Hochberg, MD, PhD..
NCT00912041 is a NA study of Spinal Cord Injuries and Amyotrophic Lateral Sclerosis that is actively recruiting participants, run by Leigh R. Hochberg, MD, PhD.. The registered enrollment target is 27 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (56% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00912041, a NA study of Spinal Cord Injuries and Amyotrophic Lateral Sclerosis, is actively recruiting participants, sponsored by Leigh R. Hochberg, MD, PhD..
- RECRUITING
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.
Conditions Studied
Interventions
- DEVICE Placement of the BrainGate2 sensor(s) into the motor-related cortex
Study Locations (5)
California
- University of California, Davis - Sacramento
- Stanford University School of Medicine - Stanford
Georgia
- Emory University School of Medicine - Atlanta
Massachusetts
- Massachusetts General Hospital - Boston
Rhode Island
- Providence VA Medical Center - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2009-05 |
| Est. Completion | 2038-12 |
| Phase | NA |
What NCT00912041 shows while recruiting
NCT00912041 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (56% lower).
The record links to 6 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Placement of the BrainGate2 sensor(s) into the motor-related cortex is the first listed.
NCT00912041 lists 5 locations in 4 states (California, Georgia, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT00912041 about?
NCT00912041 is a clinical study titled "BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia". The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.
What is the current status of trial NCT00912041?
This trial is currently recruiting. It is a NA study. The enrollment target is 27 participants. The study started on 2009-05. Estimated completion is 2038-12.
What conditions does trial NCT00912041 study?
This clinical trial studies the following conditions: Spinal Cord Injuries, Amyotrophic Lateral Sclerosis, Tetraplegia, Muscular Dystrophy, Locked-in Syndrome.
What interventions are being tested in trial NCT00912041?
The interventions under investigation include: Placement of the BrainGate2 sensor(s) into the motor-related cortex (DEVICE).
Who is sponsoring clinical trial NCT00912041?
This trial is sponsored by Leigh R. Hochberg, MD, PhD., which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00912041 being conducted?
This trial has 5 study locations across California, Georgia, Massachusetts, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00912041's enrollment target sits among peer trials
27 105th of 202 higher than 96 of 202 other Spinal Cord Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Closed-loop Spinal Stimulation for Restoration of Upper Extremity Function After Spinal Cord Injury
RECRUITING · NA
-
Neuromodulation to Improve Respiratory Function in Cervical Spinal Cord Injury
RECRUITING · NA
-
Transcutaneous Spinal Stimulation and Exercise for Locomotion
RECRUITING · NA
-
HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A Feasibility Study
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
- NCT03690011 · 27 participants · Phase 1
Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia